Hepatitis C is a viral infection that affects your liver. You may not have symptoms. Hepatitis C is a viral infection caused by the hepatitis C virus (HCV) that affects the liver. It can be acute ...

In 2023, there were an estimated 68,890 people living with hepatitis C in Australia, down 58% from 162,590 at the end of 2015 ...

The following is a summary of “Hepatitis C Virus Testing Among Perinatally Exposed Children: 2018 to 2020,” published in the ...

The development of an effective vaccine against the hepatitis C virus (HCV) has posed a significant challenge for decades due to the high genetic diversity of the virus. A research team has now ...

The hepatitis C virus usually spreads through blood. The most common way that people get it is from injecting drugs -- especially when they share needles or syringes. The risk of getting hepatitis ...

If you're looking for ways to treat hepatitis C, you have more choices than ever before, including antiviral medicines that cure the disease (the first-line treatment for hep C). But some people ...

Older drugs could potentially advance U.S. hepatitis C elimination efforts. The government could act like a business and use all current and historical market information to its advantage.

More than 250 million people live with chronic hepatitis B, making it the most common chronic infection worldwide.1 Despite effective tools to prevent transmission, diagnosis, and treatment, hepatitis ...

Alcohol-induced hepatitis is liver damage caused by over-consuming alcohol. It can progress to severe liver scarring called cirrhosis if you continue alcohol use. Alcohol-induced hepatitis ...

Key exclusion criteria were infection with hepatitis A, C, D, or E virus or human immunodeficiency virus, clinically significant liver fibrosis or cirrhosis (fibrosis stage ≥F3 on liver biopsy o ...

Chi-Chi's, the popular Mexican restaurant chain that shut down in 2004 after one of its venues was linked to the largest outbreak of hepatitis A in U.S. history, is making a comeback next year.

When news broke in 2014 that hepatitis C, a viral disease affecting the liver, could be cured thanks to a new class of direct-acting antiviral drugs, many began to wonder how soon it would be before ...